Menu
Doctor's prescription
Cerolip
Download Leaflet Listen leaflet
Product Package Image
Image for illustrative purposes only.
Indication
Está indicado para el tratamiento de Hiperlipidemia primaria resistente a manejo con dieta apropiada, incluyendo hipercolesterolemia, hipertrigliceridemia e hiperlipidemia mixta. En la clasificación de Fredrickson estas entidades corresponden a los tipos IIa, IIb, III y IV.
Active Ingredient
Ciprofibrato
Concentration
100 mg
Presentation
30 tabletas
Practical information
Coated tablet
Antilipemic
Sale under medical prescription
Doctor's prescription
Contraindication
Pacientes con conocida hipersensibilidad al Ciprofibrato o alguno de los excipientes. Daño hepático severo. Daño renal severo. Embarazo y lactancia. Uso concomitante con inhibidores de la HMG-CoA reductasa y otros fibratos. Cirrosis biliar primaria. Estado hipoalbumineicos.
Published in: October 6, 2020  
and updated in: April 2, 2025
Registration PF-31827
Eurofarma
About The Company Areas of Expertise Join Our Staff Certifications Warnings Awards and Recognition Visitation Program Where We Operate
Products
Generic Drugs Hospital Nonprescription Drugs Oncology Prescription Drugs
Innovation
Biotechnology Eurolab New Business Conduct Clinical Research With Us Research and Development EurON
Sustainability
Sustainability Booklet Corporate Governance Annual Report Corporate Responsibility Sustainability Vision Balance Sheet
© Eurofarma 2025
Privacy Policy